Ho Sik Shin (Kosin University Gospel Hospital)

2013~2015: Ph.D. (Internal Medicine) Kosin University

2004~2006: M.S. (Internal Medicine) Kosin University

1993~1999: M.D. Kosin University, College of Medicine

2021 ─ present, Professor in Nephrology, Kosin University Gospel Hospital

2020 ─ present, Director, Transplantation Research Institute, Kosin University College of Medicine

2022 ─ Director, the Dialysis Quality Assurance in The Korean Society of Nephrology

Prof. Ho Sik Shin is a physician-scientist and transplant nephrologist at Kosin University Gospel Hospital, Busan, South Korea. He undertook post-doctoral research with Anil Chandraker at the Harvard Medical School, Transplantation Research Center of Brigham & Women’s Hospital. Currently he is director of Transplantation Research Institute of Kosin University College of Medicine, member of Korean Society of Transplantation, and Korean Society of Nephrology. He is currently undertaking research for Immune tolerane of transplantation (esp, regulatory T cells) and ESRD.

Clinical Efficacy of a Home-based Peritoneal Dialysis Management Program. Kidney Int Rep. 2025 Sep 5;10(11):3874-3883. doi: 10.1016/j.ekir.2025.08.040. eCollection 2025 Nov.

Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation. BMC Infect Dis. 2025 Mar 5;25(1):314. doi: 10.1186/s12879-025-10671-6.

Effects of shared decision-making on the prognosis of peritoneal dialysis patients. Medicine (Baltimore). 2024 Nov 22;103(47):e40659. doi: 10.1097/MD.0000000000040659.

Kidney transplantation in the elderly. Park BH, Kil SY, Kim YN, Shin HS, Jung Y, Rim H. Korean J Intern Med. 2024 Nov;39(6):875-881. doi: 10.3904/kjim.2024.089. Epub 2024 Oct 24.

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report. Kidney Res Clin Pract. 2024 Sep 11. doi: 10.23876/j.krcp.24.067. Online ahead of print.